Antisense RNA-mediated reduction of p53 induces malignant phenotype in nontumorigenic rat urothelial cells

Carcinogenesis

Volumn 19, Issue 1, 1998, Pages 73-79

  Okamoto, Masato ^a   Hattori, Kazunori ^a   Fujimoto, Kiyohide ^a   Tanaka, Yoshinori ^a   Gloosby, Charles L ^a   Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; MESSENGER RNA; PROTEIN P16; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOGENESIS; CELL CYCLE G1 PHASE; CONTROLLED STUDY; CULTURE MEDIUM; GENE MUTATION; GENETIC TRANSFECTION; LUNG METASTASIS; METHODOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RAT; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT CANCER;

ANIMALS; CELL CYCLE; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; GENES, P53; HUMANS; MICE; MICE, NUDE; POLYMERASE CHAIN REACTION; RATS; RNA, ANTISENSE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 0031843626     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.1.73     Document Type: Article

References (36)

1. Finlay, C.A. and Hinds, P.W. (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093.
2. Levine, A.J., Momand, J. and Finlay, C.A. (1991) The p53 tumor suppressor gene. Nature, 351, 453-456.
3. Bodner, S.M., Minna, J.D., Jensen, S.M., D'Amico, D., Carbone, D., Mitsudomi, T., Fedorko, J., Buchhagen, D.L., Nau, M.M., Grazdar, A.F. and Linnoila, I. (1992) Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene, 7, 743-749.
4. Sidransky, D., von Eschenbach, A., Tsai, Y.C., Jones, P., Summerhays, I., Marshall, F., Paul, M., Green, P., Hamilton, S.R., Frost, P. and Vogelstein, B. (1991) Identification of p53 gene mutations in bladder cancers and urine samples. Science, 252, 706-709.
5. Presti, J.C., Jr, Reuter, V.E., Galan, T, Fair, W.R. and Cordon-Cardo, C. (1991) Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res., 51, 5405-5409.
6. Fujimoto, K., Yamada, Y., Okajima, E., Kakizoe, T., Sasaki, H., Sugimura, T. and Terada, M. (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398.
7. Dalbagni, G., Presti, J.C., Jr, Reuter, V.E., Zhang, Z.F., Sarkis, A.S., Fair, W.R. and Cordon-Cardo, C. (1993) Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn. Mol. Pathol., 2, 4-13.
8. Oyasu, R., Nan, L., Szumel, R.C., Kawamata, K. and Hirohashi, S. (1995) p53 gene mutation in human urothelial carcinomas: Analysis by immunohistochemistry and single-strand conformation polymorphism. Modern Pathol., 8, 170-176.
9. Olumi, A.F., Tsai, Y.C., Nichols, P.W., Skinner, D.G., Cain, D.R., Bender, L.I. and Jones, P.A. (1990) Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res., 50, 7081-7083.
10. Spruck III, C.H., Ohneseit, P.F. Gonzalez-Zulueta, M., Esrig, D., Miyao, N., Tsai, Y.C., Lerner, S.P., Schmutte, C., Yang, A.S., Cote, R., Dubeau, L., Nichols, P.W., Hermann, G.G., Steven, K., Horn, T., Skinner, D.G. and Jones, P.A. (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res., 54, 784-788.
11. Masui, T., Don, I., Takada, N., Ogawa, K., Shirai, T. and Fukushima, S. (1994) p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl) nitrosamine. Carcinogenesis, 15, 2379-2381.
12. Sarkis, A.S., Dalbagni, G., Cordon-Cardo, C., Melamed, J., Zhang, Z.F., Sheinfeld, J., Fair, W.R., Herr, H.W. and Reuter, V.E. (1994) Association of p53 nuclear overexpression and tumor progression in carcinoma in situ of the bladder. J. Urol., 152, 388-392.
13. Esrig, D., Elmajian, D., Groshen, S., Freeman, J.A., Stein, J.P., Chen, S.C., Nichols, P.W., Skinner, D.G., Jones, P.A. and Cote, R.J. (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. New Eng. J. Med., 331, 1259-1264.
14. Kawamata, H., Kameyama, S., Nan, L., Kawai, K. and Oyasu, R. (1993) Effect of epidermal growth factor and transforming growth factor β1 on growth and invasive potentials of newly established rat bladder carcinoma cell lines. Int. J. Cancer, 55, 968-973.
15. Soussi, T., de Fromentel, C.C., Breugnot, C. and May, E. (1988) Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Nucleic Acids Res., 16, 1384.
16. Mashiyama, S., Sekiya, T. and Hayashi, K. (1990) Screening of multiple DNA samples for detection of sequence changes. J. Methods Cell Mol. Biol., 2, 304.
17. Takebe, Y., Seiki, M., Fujisawa, J., Hoy, P., Yokota, K., Arai, K., Yoshida, M. and Arai, N. (1988) SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol., 8, 466-472.
18. Maniatis, T., Eritsch, E.F. and Sambrook, J. (1988) Expression of cloned genes in cultured mammalian cells. In Nolan, C. (ed.), Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, NY, 2nd Edn, p. 47.
19. Berger, S.L. and Birkenmeier, C.S. (1979) Inhibition of intractable nucleases with ribonucleoside-vanadyl complexes: Isolation of messenger ribonucleic acid from resting lymphocytes. Biochemistry, 18, 5143-5149.
20. Northemann, W., Braciak, T.A., Hattori, M., Lee, F. and Fey, G.H. (1989) Structure of the rat interleukin 6 gene and its expression in macrophagederived cells. J. Biol. Chem., 264, 16072-16082.
21. Carmichael, J., de Graff, W.G., Gazdar, A.F, Minna, J.D. and Mitchell, J.B. (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res., 47, 936-942.
22. Kameyama, S., Kawamata, H., Kawai, K. and Oyasu, R. (1993) A new in vivo model for studying invasion and metastasis of rat and human bladder carcinomas. Carcinogenesis, 14, 1531-1535.
23. Santhanam, U., Ray, A. and Sehgal, P.B. (1991) Repression of the interleukin 6 gene promoter by p53 and the retroblastoma susceptibility gene product. Proc. Natl Acad. Sci. USA, 88, 7605-7609.
24. Margulies, L. and Sehgal, P.B. (1993) Modulation of the human interleukin6 promoter (IL-6) and transcription factor C/EBPb (NF-IL6) activity by p53 species. J. Biol. Chem., 268, 15096-15100.
25. 175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6. FEBS Lett., 353, 29-32.
26. Okamoto, M., Kawamata, H., Kawai, K. and Oyasu, R. (1995) Enhancement of transformation in vitro of a nontumorigenic rat urothelial cell line by interleukin 6. Cancer Res., 55, 4581-4585.
27. Watson, J.M., Sensintaffar, J.L., Berek, J.S. and Martinez-Maza, O. (1990) Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res., 50, 6959-6965.
28. Osifchin, N.E., Jiang, D., Fujita, N., Fujita, T., Carroza, M., Kim, S.J., Sakai, T. and Robbins, P.D. (1994) Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter. J. Biol. Chem., 269, 6383-6389.
29. Shiio, Y., Yamamoto, T. and Yamaguchi, N. (1992) Negative regulation of Rb expression by the p53 gene product. Proc. Natl Acad. Sci. USA, 89, 5206-5210.
30. Cordon-Cardo, C. (1995) Mutation of cell cycle regulators: Biological and clinical implications for human neoplasia. Am. J. Pathol., 147, 545-560.
31. El-Diery, W., Tokino, T., Velculescu, V., Levy, D., Parsons, R., Trent, J., Lin, D., Mercer, E., Kinzler, K. and Vogelstein, B. (1993) WAF 1 a potential mediator of p53 tumor suppression. Cell, 75, 817-825.
32. Noda, A., Ning, Y., Venable, S.F., Percira-Smith, O.M. and Smith, J.R. (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res., 211, 90-98.
33. Dulic, V., Kaufmann, W.K., Wilson, S.J., Tlsty, T.D., Lees, E., Harper, J.W., Elledge, S.J. and Reed, S.I. (1994) p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76, 1013-1023.
34. Reznikoff, C.A., Yeager, T.R., Belair, C.D., Savelieva, E., Puthenveettil, J.A. and Stadler, W.M. (1996) Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16E6, but not E7, transformed human uroepithelial cells. Cancer Res., 56, 2886-2890.
35. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A., Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature, 355, 846-847.
36. Harvey, M., McArthur, M.J., Montgomery, C.A., Butel, J.S., Bradley, A. and Donehower, L.A. (1993) Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat. Genet., 5, 225-229.